Skip to content

Non-Hodgkin's Lymphoma

Font Size

Changes to This Summary (02 / 19 / 2013)


    Added text to state that in a meta-analysis of 2,586 patients with follicular lymphoma, nine randomized clinical trials compared rituximab maintenance with no maintenance and showed improved overall survival (OS) for rituximab maintenance in previously treated patients (cited Vidal et al. as reference 56 and level of evidence: 1iiA).

    Added Al Khabori et al. as reference 66.

    Added text to the list of treatment options under clinical evaluation to include ofatumumab, a human anti-CD20 monoclonal antibody (cited Czuczman et al. as reference 71) and short-course low-dose, palliative radiation therapy (cited Chan et al. and Rossier et al. as references 72 and 73, respectively).

    Treatment for Aggressive, Stage I and Contiguous Stage II Adult NHL

    Revised text to state that with a median follow-up of 72 months, the event-free survival favored R-CHOP given every 2 weeks for six or eight cycles. Also revised statistics about OS favoring R-CHOP for only six cycles because of increased toxicity in the eight-cycle arm (cited Pfreundschuh et al. as reference 8).

    Treatment for Aggressive, Noncontiguous Stage II/III/IV Adult NHL

    Added text to state that a trial of 380 patients younger than 60 years with diffuse large B-cell lymphoma and an age-adjusted International Prognostic Index rating of 1 randomized treatment to ACVBP + rituximab versus CHOP + rituximab; with a median follow-up of 44 months, 3-year OS favored R-ACVBP (cited Récher et al. as reference 7 and level of evidence: 1iiA).

    This summary is written and maintained by the PDQ Adult Treatment Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ NCI's Comprehensive Cancer Database pages.

    This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http:// cancer .gov or call 1-800-4-CANCER.

    WebMD Public Information from the National Cancer Institute

    Last Updated: February 25, 2014
    This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information.

    Today on WebMD

    stem cells
    What are they and why do we need them?
    Lung cancer xray
    See it in pictures, plus read the facts.
    sauteed cherry tomatoes
    Fight cancer one plate at a time.
    Ovarian cancer illustration
    Do you know the symptoms?
    Vitamin D
    New Treatments For Non-Hodgkins Lymphoma
    Lifestyle Tips for Depression Slideshow
    Pets Improve Your Health

    WebMD Special Sections